The largest database of trusted experimental protocols

Anti human cd25 fitc

Manufactured by BD
Sourced in United States

Anti-human CD25-FITC is a fluorochrome-conjugated antibody that binds to the CD25 antigen expressed on the surface of activated T cells and regulatory T cells. It is used for the identification and enumeration of these cell populations in flow cytometry applications.

Automatically generated - may contain errors

2 protocols using anti human cd25 fitc

1

T-cell Proliferation and Apoptosis Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Forty-eight hours after activation, T cells were added with 1 µCi/well of [3H]-thymidine (American Radiolabeled Chemicals, St. Louis, MO, USA) for 16 hours and harvested, and the radioactivities were measured in a scintillation β-counter (MicroBeta, Trilux, PerkinElmer, Turku, Finland). All samples were quadripicated.
For apoptosis analysis, T cells were cultured in a 24-well plate in a CO2 incubator at 37℃, added with various concentrations of vitamin C up to 1 mM for 2 hours, and activated with PMA/ionomycin. After 24 hours, 1×106 cells were suspended in Annexin V binding buffer (BD Pharmingen, Franklin Lakes, NJ, USA) and incubated with Annexin V (BD Pharmingen) for 15 minutes. Propidium iodide (PI) (BD Pharmingen) was added just before flow cytometric analysis.
For the analysis of activation marker expression, human T cells in a fluorescence-activated cell sorting (FACS) tube (1×106/tube) were washed twice in cold PBS containing 0.05% bovine serum albumin (Amresco, Solon, OH, USA), incubated with anti-human CD69-FITC (BD Pharmingen) and anti-human CD25-FITC (BD Pharmingen) antibodies, 0.2 µg each on ice, and subjected to flow cytometric analysis.
Flow cytometric analysis was performed using FACS Calibur (BD Biosciences, San Diego, CA, USA).
+ Open protocol
+ Expand
2

Macrophages Induce Treg Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess whether macrophages in the presence of BM-MSCs generated Tregs, macrophages were first treated with BM-MSCs without cellular contact in a 0.4 µm Transwell system (Corning) for 6 days in the presence of M0, M1 or M2 inducer medium, after which they were cocultured with CD4 + T cells selected using CD4 MicroBeads (Miltenyi Biotec) in a 1:1 ratio (macrophages:T cells) in RPMI medium (HyClone) containing 10% FBS (Corning) in the presence of anti-CD2/CD3/CD28 beads (1:1 T cell ratio) (Miltenyi Biotec). After 5 days of coculture, T lymphocytes were harvested and blocked with FBS (Biowest) at 4 • C for 15 min. After blocking, anti-human CD4-PE (BD Biosciences) and anti-human CD25-FITC (BD Biosciences) antibodies were added. The cells were then permeabilized following the manufacturer's instructions with the FoxP3 staining buffer set kit (Invitrogen). After permeabilization, anti-human FoxP3-APC (Biolegend) was added. Acquisitions were made on a spectral flow cytometer Aurora (Cytek Biosciences) and analyzed with FlowJo V10 software (Supplementary Figure S1). CD4+ T lymphocytes cultured in the absence of macrophages were used as a control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!